Nancy Avis to Time Factors
This is a "connection" page, showing publications Nancy Avis has written about Time Factors.
Connection Strength
0.645
-
Avis NE, Colvin A, Karlamangla AS, Crawford S, Hess R, Waetjen LE, Brooks M, Tepper PG, Greendale GA. Change in sexual functioning over the menopausal transition: results from the Study of Women's Health Across the Nation. Menopause. 2017 04; 24(4):379-390.
Score: 0.103
-
Avis NE, Levine BJ, Case LD, Naftalis EZ, Van Zee KJ. Trajectories of depressive symptoms following breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1789-95.
Score: 0.092
-
Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, Hess R, Joffe H, Kravitz HM, Tepper PG, Thurston RC. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015 Apr; 175(4):531-9.
Score: 0.090
-
Danhauer SC, Case LD, Tedeschi R, Russell G, Vishnevsky T, Triplett K, Ip EH, Avis NE. Predictors of posttraumatic growth in women with breast cancer. Psychooncology. 2013 Dec; 22(12):2676-83.
Score: 0.081
-
Sohl SJ, Levine B, Case LD, Danhauer SC, Avis NE. Trajectories of illness intrusiveness domains following a diagnosis of breast cancer. Health Psychol. 2014 Mar; 33(3):232-41.
Score: 0.079
-
Danhauer SC, Crawford SL, Farmer DF, Avis NE. A longitudinal investigation of coping strategies and quality of life among younger women with breast cancer. J Behav Med. 2009 Aug; 32(4):371-9.
Score: 0.059
-
Foley KL, Farmer DF, Petronis VM, Smith RG, McGraw S, Smith K, Carver CS, Avis N. A qualitative exploration of the cancer experience among long-term survivors: comparisons by cancer type, ethnicity, gender, and age. Psychooncology. 2006 Mar; 15(3):248-58.
Score: 0.048
-
Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, Brunner EJ, Kuh D, Hardy R, Avis NE, Gold EB, Derby CA, Matthews KA, Cade JE, Greenwood DC, Demakakos P, Brown DE, Sievert LL, Anderson D, Hayashi K, Lee JS, Mizunuma H, Tillin T, Simonsen MK, Adami HO, Weiderpass E, Mishra GD. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019 11; 4(11):e553-e564.
Score: 0.031
-
Zhu D, Chung HF, Pandeya N, Dobson AJ, Cade JE, Greenwood DC, Crawford SL, Avis NE, Gold EB, Mitchell ES, Woods NF, Anderson D, Brown DE, Sievert LL, Brunner EJ, Kuh D, Hardy R, Hayashi K, Lee JS, Mizunuma H, Giles GG, Bruinsma F, Tillin T, Simonsen MK, Adami HO, Weiderpass E, Canonico M, Ancelin ML, Demakakos P, Mishra GD. Relationships between intensity, duration, cumulative dose, and timing of smoking with age at menopause: A pooled analysis of individual data from 17 observational studies. PLoS Med. 2018 11; 15(11):e1002704.
Score: 0.029
-
Drafts BC, Twomley KM, D'Agostino R, Lawrence J, Avis N, Ellis LR, Thohan V, Jordan J, Melin SA, Torti FM, Little WC, Hamilton CA, Hundley WG. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. JACC Cardiovasc Imaging. 2013 Aug; 6(8):877-85.
Score: 0.020
-
Greendale GA, Huang MH, Wight RG, Seeman T, Luetters C, Avis NE, Johnston J, Karlamangla AS. Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology. 2009 May 26; 72(21):1850-7.
Score: 0.015